Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?

DOI: 10.12688/wellcomeopenres.14976.2 10.21956/wellcomeopenres.16335.r35679 10.21956/wellcomeopenres.16335.r34608

Keywords: Febrile illness, aetiology, surveillance, biomarker, C-reactive protein, Southeast Asia, rural, cost-effectiveness

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text